uniQure Ownership | Who Owns uniQure?

Overview Forecast RevenueFinancials Chart Transcripts

uniQure Ownership Summary

uniQure is owned by 37.24% institutional investors, 8.29% insiders, and 54.47% retail investors. Vestal point capital, lp is the largest institutional shareholder, holding 9.02% of QURE shares. Franklin Biotechnology Discv A(acc)USD is the top mutual fund, with 2.29% of its assets in uniQure shares.

QURE Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	uniQure	37.24%	8.29%	54.47%
Sector	Healthcare Stocks	279.18%	10.62%	-189.80%
Industry	Biotech Stocks	63.96%	10.74%	25.30%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vestal point capital, lp	4.79M	9.02%	$50.80M
Rtw investments, lp	4.27M	8.03%	$45.21M
Ecor1 capital	3.40M	6.98%	$60.04M
Nantahala capital management	2.76M	5.19%	$29.21M
Avoro capital advisors	2.17M	4.10%	$23.05M
Franklin resources	1.99M	4.08%	$35.10M
Blackrock	1.93M	3.98%	$8.63M
Point72 asset management	1.77M	3.64%	$31.28M
683 capital management	1.52M	3.13%	$26.93M
Abrdn	1.51M	3.10%	$26.65M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Vestal point capital, lp	4.79M	3.63%	$50.80M
Stempoint capital lp	731.04K	2.47%	$7.75M
Ecor1 capital	3.40M	2.27%	$60.04M
683 capital management	1.52M	1.67%	$26.93M
Integral health asset management	1.25M	1.41%	$13.25M
Nantahala capital management	2.76M	1.16%	$29.21M
Birchview capital, lp	88.70K	0.82%	$940.19K
Rtw investments, lp	4.27M	0.69%	$45.21M
Privium fund management b.v.	640.42K	0.66%	$2.57M
Parkman healthcare partners	275.00K	0.65%	$4.86M

Top Buyers

Holder	Shares	% Assets	Change
Ecor1 capital	3.40M	2.27%	3.40M
Rtw investments, lp	4.27M	0.69%	3.36M
Vestal point capital, lp	4.79M	3.63%	1.77M
Point72 asset management	1.77M	0.07%	794.46K
Stempoint capital lp	731.04K	2.47%	641.04K

Top Sellers

Holder	Shares	% Assets	Change
Schroder investment management group	834.08K	0.01%	-634.57K
Ikarian capital	-	-	-469.13K
Hudson bay capital management lp	175.00K	0.01%	-460.50K
Alphacentric advisors	-	-	-460.00K
Avidity partners management lp	222.00K	0.39%	-451.62K

New Positions

Holder	Shares	% Assets	Change	Value
Ecor1 capital	3.40M	2.27%	3.40M	$60.04M
Sofinnova investments	545.77K	0.38%	545.77K	$5.79M
Affinity asset advisors	400.00K	0.40%	400.00K	$4.24M
Lord, abbett	314.41K	0.02%	314.41K	$5.55M
Parkman healthcare partners	275.00K	0.65%	275.00K	$4.86M

Sold Out

Holder	Change
Northwestern mutual wealth management	-1.00
Nelson, van denburg & campbell wealth management group	-32.00
Pineridge advisors	-38.00
Financial gravity asset management	-49.00
Point72 (difc)	-52.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	23	-85.35%	19,779,316	-52.46%	37	0.51%	14	-81.08%	5	-89.36%
Dec 31, 2024	148	4.23%	38,592,241	-0.74%	79	1.24%	68	-2.86%	45	21.62%
Sep 30, 2024	141	9.30%	38,878,066	22.43%	79	1.85%	69	23.21%	37	-
Jun 30, 2024	129	-6.52%	31,756,298	-1.57%	65	1.44%	56	-22.22%	37	15.63%
Mar 31, 2024	138	-11.54%	32,262,781	-13.94%	67	1.10%	72	-	32	-43.86%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Franklin Biotechnology Discv A(acc)USD	1.25M	2.29%	-
abrdn Healthcare Investors	1.25M	2.29%	101.83K
SPDR® S&P Biotech ETF	931.81K	1.70%	1.21K
International Biotechnology Ord	800.17K	1.46%	-389.95K
Delaware Healthcare I	706.17K	1.45%	-
Vanguard Institutional Extnd Mkt Idx Tr	790.41K	1.45%	2.54K
Macquarie Healthcare I	706.17K	1.29%	-
Franklin Biotechnology Discovery A	696.40K	1.27%	-37.10K
abrdn World Healthcare	585.08K	1.07%	61.47K
abrdn Life Sciences Investors	584.30K	1.07%	42.05K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 04, 2025	Kapusta Matthew C	CEO, Managing Director	Sell	$291.63K
Mar 04, 2025	Abi-Saab Walid	Chief Medical Officer	Sell	$13.89K
Mar 04, 2025	KLEMT CHRISTIAN	Chief Financial Officer	Sell	$107.41K
Mar 04, 2025	Potts Jeannette	Chief Legal Officer	Sell	$72.81K
Feb 25, 2025	Kapusta Matthew C	CEO, Managing Director	Sell	$285.98K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	8
2024 Q4	-	3
2024 Q2	-	12
2024 Q1	-	3
2023 Q4	-	-

QURE Ownership FAQ

Who Owns uniQure?

uniQure shareholders are primarily institutional investors at 37.24%, followed by 8.29% insiders and 54.47% retail investors. The average institutional ownership in uniQure's industry, Biotech Stocks , is 63.96%, which uniQure falls below.

Who owns the most shares of uniQure?

uniQure’s largest shareholders are Vestal point capital, lp (4.79M shares, 9.02%), Rtw investments, lp (4.27M shares, 8.03%), and Ecor1 capital (3.4M shares, 6.98%). Together, they hold 24.03% of uniQure’s total shares outstanding.

Does Blackrock own uniQure?

Yes, BlackRock owns 3.98% of uniQure, totaling 1.93M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 8.63M$. In the last quarter, BlackRock increased its holdings by 65.08K shares, a 3.50% change.

Who is uniQure’s biggest shareholder by percentage of total assets invested?

Vestal point capital, lp is uniQure’s biggest shareholder by percentage of total assets invested, with 3.63% of its assets in 4.79M uniQure shares, valued at 50.8M$.

Who is the top mutual fund holder of uniQure shares?

Franklin Biotechnology Discv A(acc)USD is the top mutual fund holder of uniQure shares, with 2.29% of its total shares outstanding invested in 1.25M uniQure shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools